Study of How Itraconazole Affects ABBV-722 in Healthy Adults
Treatments studied
This early-stage study tests how a common antifungal medicine (itraconazole) affects how the body processes an experimental drug called ABBV-722. Researchers enroll only healthy people to safely measure these interactions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in generally good health with normal lab work, blood pressure, heart rhythm, and physical exam
- No major illness, infection, hospitalization, or surgery in the past 30 days
- No use of tobacco or nicotine products for at least 3 months
- No alcohol, grapefruit, Seville oranges, starfruit, or tonic water for 72 hours before the study starts
- You have never received ABBV-722 before, or not within the past 90 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called ABBV-313 in healthy adults to see if it is safe and how the body handles it. You will receive either a single injection or infusion, or multiple doses, to help researchers understand its effects.
This study tests a new drug called ABBV-243 in healthy adults to see if it is safe and how the body processes it. Participation helps researchers understand the drug before studying it in people with a disease.
This study tests how a new experimental drug (BGB-58067) moves through your body and how two common medications affect that process. Researchers need healthy volunteers to understand if these drug interactions are safe.
This study tests an investigational drug called ABBV-932 in people with bipolar disorder. It looks at how the drug moves through the body when taken with another medication (itraconazole) and checks for any side effects.
This study tests how a common antifungal medication (itraconazole) affects how the body processes an experimental drug called nacresertib. Researchers want to understand if taking both drugs together is safe and how they interact in healthy volunteers.
This trial tests the safety of a new oral drug, ABBV-1042, in healthy adults. It helps researchers understand how the drug moves through the body and what side effects may occur.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.